These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 17240435

  • 1. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 2. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
    Ai Z, Wang J, Wang Y, Lu L, Tong J, Teng Y.
    Cancer; 2010 Aug 01; 116(15):3603-13. PubMed ID: 20564127
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y, Tong J, Ai Z, Wang J, Teng Y.
    J Obstet Gynaecol Res; 2012 Dec 01; 38(12):1358-66. PubMed ID: 22612393
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ.
    Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC, Dotzlaw H, Wong MS, Miller T, Murphy LJ.
    Cancer Res; 1991 Apr 15; 51(8):2051-7. PubMed ID: 1849041
    [Abstract] [Full Text] [Related]

  • 6. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB, Kaino T, Sager G, Arnes M, Ørbo A.
    Gynecol Oncol; 2006 May 15; 101(2):214-23. PubMed ID: 16325240
    [Abstract] [Full Text] [Related]

  • 7. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
    Zhao SJ, Chen XJ, Feng YJ.
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr 15; 40(2):103-12. PubMed ID: 17580663
    [Abstract] [Full Text] [Related]

  • 8. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ.
    Am J Obstet Gynecol; 2001 Apr 15; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [Abstract] [Full Text] [Related]

  • 9. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
    Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris JM, Simila HA, Moore NL, Bentel JM, Ricciardelli C, Horsfall DJ, Butler LM, Tilley WD.
    Cancer Res; 2005 Sep 15; 65(18):8487-96. PubMed ID: 16166329
    [Abstract] [Full Text] [Related]

  • 10. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ, Shi HR, Xie Y.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb 15; 51(2):135-40. PubMed ID: 26917483
    [Abstract] [Full Text] [Related]

  • 11. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D, Tang XM, Ma C, Chegini N.
    Gynecol Oncol; 2001 May 15; 81(2):301-9. PubMed ID: 11330966
    [Abstract] [Full Text] [Related]

  • 12. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D, Kumar NS, Wolf DM, Leslie KK.
    Am J Obstet Gynecol; 2001 Apr 15; 184(5):790-7. PubMed ID: 11303185
    [Abstract] [Full Text] [Related]

  • 13. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT, Sarvilinna NS, Purmonen SR, Ylikomi TJ.
    Steroids; 2009 Apr 15; 74(4-5):404-9. PubMed ID: 19146866
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
    Kashima H, Horiuchi A, Uchikawa J, Miyamoto T, Suzuki A, Ashida T, Konishi I, Shiozawa T.
    Anticancer Res; 2009 Apr 15; 29(4):1023-9. PubMed ID: 19414341
    [Abstract] [Full Text] [Related]

  • 15. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS, Qamar L, Behbakht K, Post MD, Sheeder J, Sartorius CA, Spillman MA.
    Gynecol Oncol; 2016 Mar 15; 140(3):518-26. PubMed ID: 26731726
    [Abstract] [Full Text] [Related]

  • 16. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
    Singh M, Zaino RJ, Filiaci VJ, Leslie KK.
    Gynecol Oncol; 2007 Aug 15; 106(2):325-33. PubMed ID: 17532033
    [Abstract] [Full Text] [Related]

  • 17. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
    Hanekamp EE, Kühne LM, Grootegoed JA, Burger CW, Blok LJ.
    Endocr Relat Cancer; 2004 Dec 15; 11(4):831-41. PubMed ID: 15613456
    [Abstract] [Full Text] [Related]

  • 18. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y, Shibutani Y, Aoki D, Nozawa S.
    Cancer; 1997 Jan 01; 79(1):169-76. PubMed ID: 8988742
    [Abstract] [Full Text] [Related]

  • 19. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV.
    Oncogene; 2006 Dec 14; 25(59):7723-39. PubMed ID: 16799639
    [Abstract] [Full Text] [Related]

  • 20. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
    Wang Y, Zhang L, Che X, Li W, Liu Z, Jiang J.
    Arch Gynecol Obstet; 2018 Nov 14; 298(5):961-969. PubMed ID: 30206735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.